Zanamivir is an antiviral medication primarily used to treat and prevent influenza, commonly known as the flu. It belongs to a class of drugs called neuraminidase inhibitors, which work by blocking the action of the neuraminidase enzyme on the surface of the influenza virus. This action helps to stop the virus from spreading within the body, thereby reducing the severity and duration of flu symptoms.
Zaleplon is a prescription medication primarily used to treat insomnia, a condition most characterized by difficulty falling asleep. It belongs to a class of drugs known as sedative-hypnotics, which work by affecting certain chemicals in the brain that may be unbalanced in people with sleep disorders. Zaleplon is known for its rapid onset of action, making it particularly useful for individuals who struggle with sleep initiation.
Zafirlukast is a medication primarily used to manage asthma and prevent asthma attacks. It belongs to a class of drugs known as leukotriene receptor antagonists (LTRAs). By blocking the action of leukotrienes?substances in the body that cause inflammation, bronchoconstriction, and mucus production?zafirlukast helps to reduce airway inflammation and improve asthma control in individuals with asthma.
Zafirlukast is approved for the following medical uses:
Vutrisiran is a novel medication designed to treat hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), a rare and progressive disease caused by the accumulation of amyloid proteins in various tissues and organs. This condition can lead to severe complications, including neuropathy and cardiomyopathy. Vutrisiran works by reducing the production of the transthyretin protein, thereby helping to manage the symptoms and progression of the disease.
Voxelotor is a medication primarily used to treat sickle cell disease, a genetic blood disorder characterized by the production of abnormal hemoglobin, leading to distorted red blood cells. This innovative drug works by increasing hemoglobin's affinity for oxygen, thereby reducing the sickling of red blood cells and improving overall blood flow. Approved by the FDA in 2019, Voxelotor represents a significant advancement in the management of sickle cell disease, offering patients a new option to alleviate symptoms and improve their quality of life.
Vortioxetine is a prescription medication primarily used to treat major depressive disorder (MDD) in adults. It belongs to a class of drugs known as serotonin modulators and stimulators. Vortioxetine is unique in its ability to enhance serotonin levels in the brain while also affecting various serotonin receptors, which may contribute to its antidepressant effects. This medication is often considered when other treatments have not been effective, providing an alternative for those struggling with depression.
Vorinostat, also known by its brand name Zolinza, is a medication primarily used in the treatment of certain types of cancer. It belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors. Vorinostat works by altering the expression of genes involved in cell growth and survival, making it particularly effective in treating cutaneous T-cell lymphoma (CTCL) in patients who have received prior therapies.
Vorinostat is primarily approved for the treatment of:
Vorapaxar is a medication primarily used to reduce the risk of heart attacks and strokes in patients with a history of cardiovascular issues. It belongs to a class of drugs known as protease-activated receptor 1 (PAR1) antagonists. By inhibiting a specific receptor involved in platelet activation, Vorapaxar helps prevent blood clots, making it a valuable option for patients at high risk of thrombotic events.
Voglibose is an oral medication primarily used to manage blood sugar levels in individuals with type 2 diabetes. It belongs to a class of drugs known as alphaglucosidase inhibitors, which work by slowing down the digestion of carbohydrates in the intestines. This helps to prevent spikes in blood sugar levels after meals, making it an essential part of diabetes management for many patients.
Voclosporin is a medication primarily used in the treatment of lupus nephritis (LN), a kidney manifestation of systemic lupus erythematosus (SLE). It belongs to a class of drugs known as calcineurin inhibitors, which help to suppress the immune system. By doing so, Voclosporin helps to reduce inflammation and prevent damage to the kidneys caused by the body's immune response.
